Juno Therapeutics Priced, Nasdaq: JUNO

Developing T-cell therapies for lymphomas, leukemias and other cancers.

Industry: Health Care

Latest Trade: $25.52 0.00 (0.0%)

First Day Return: +45.8%

Return from IPO: +6.3%

Industry: Health Care

Developing T-cell therapies for lymphomas, leukemias and other cancers.
more less
IPO News for Juno Therapeutics
more
IPO Data
IPO File Date 11/17/2014
Offer Price $24.00
Price Range $21.00 - $23.00
Offer Shares (mm) 11.0
Deal Size ($mm) $265
IPO Data
IPO Date 12/18/2014
Offer Price $24.00
Price Range $21.00 - $23.00
Offer Shares (mm) 11.0
Deal Size ($mm) $265
Underwriters
more
Company Data
Headquarters Seattle, WA
Founded 2013
Employees 70
Website www.junotherapeutics.com